PHAR
Pharming Group
PHAR
PHAR
3 hedge funds and large institutions have $325K invested in Pharming Group in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CPA
1
Cowen Prime Advisors
New York
|
$238K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$13.8K |
| 2 |
2
Morgan Stanley
New York
|
$73.3K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CPA
1
Cowen Prime Advisors
New York
| $238K | 21,610 | +4,910 | +29% |
|
|
2
Morgan Stanley
New York
| $73.3K | 6,649 | -101 | -1% |
|
|
3
UBS Group
Zurich,
Switzerland
| $13.8K | 1,251 | -283 | -18% |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|